The market is in rally mode today–but the same can’t be said for Gilead Sciences (GILD), which has dropped nearly 2% today. RBC Capital Markets’ Michael Yee and team explain why Gilead is having trouble today:
Gilead Sciences is down ~4% this morning and some investors believe it is due to commentary by Johnson & Johnson (JNJ) (we were on the EPS call and they did not say anything specific, they just said they will work to make Olysio accessible and it will remain competitive, some investors think Olysio price will get cut — but, in our view, logically – if Sovaldi is still $84k, then Olysio does not have much of any room to go if you can just get Harvoni for $94k…..). Others think it is due to concerns around AbbVie (ABBV) needing to come in a low price (we predict this will not happen, it will be close to Sovaldi pricing) or Irish tax concerns, which we wrote about twice suggesting minimal impact here to Gilead Sciences.
Hot Growth Stocks To Invest In 2015: China Gerui Advanced Materials Group Limited(CHOP)
China Gerui Advanced Materials Group Limited engages in the manufacture and sale of cold-rolled narrow strip steel products in the People's Republic of China. The company converts steel manufactured by third parties into thin steel sheets and strips. It sells its products directly to its customers in a range of industries, including food and industrial packaging, construction and household decorations materials, electrical appliances, and telecommunications wires and cables industries. The company was formerly known as Golden Green Enterprises Limited and changed its name to China Gerui Advanced Materials Group Limited in December 2009. China Gerui Advanced Materials Group Limited is based in Zhengzhou, China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
On Tuesday, the basic materials sector proved to be a source of strength for the US market after Yellen statement. Huntsman (NYSE: HUN) shares surged 2.62 percent after reporting strong quarterly earnings, while China Gerui Advanced Materials Group (NASDAQ: CHOP) gained around 2.5 percent. - [By Monica Gerson]
China Gerui Advanced Materials Group (NASDAQ: CHOP) is expected to report its Q2 earnings.
Ambarella (NASDAQ: AMBA) is estimated to post its Q2 earnings at $0.28 per share on revenue of $44.67 million.
Top Low Price Stocks To Buy Right Now: Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp., incorporated in 1993, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threatening genetic conditions. Its lead program, SBC-102, recombinant human lysosomal acid lipase (LAL), is its advanced pipeline program in clinical development for LAL Deficiency. This enzyme is responsible for the metabolism of cholesteryl esters and triglycerides that are delivered to lysosomes by a variety of routes, including low-density lipoprotein receptor mediated endocytosis. On November 2, 2012, Trimeris, Inc. merged with Synageva BioPharma Corp.
SBC-102 is produced by recombinant deoxyribonucleic acid (DNA) technology in egg white using its protein manufacturing platform. The Company has initiated natural history studies in approximately 20 countries. In addition to SBC-102, it is progressing protein therapeutic programs for other rare diseases, which are at different stages of preclinical development. These include two enzyme replacement therapies for other lysosomal storage disorders and two programs for other rare life-threatening conditions. As of December 31, 2011, its product candidate pipeline included SBC-102, SBC-103, SBC-104, SBC-105 and SBC-106.
SBC-104 is an extracellular protein that targets a severe, rare genetic condition. SBC-105 is an enzyme replacement therapy being developed to treat a severe, rare metabolic disorder. SBC-106 is a protein therapy that targets a severe and rare genetic condition.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
- [By Garrett Cook]
Shares of Synageva BioPharma (NASDAQ: GEVA) were down 14.42 percent to $89.69 after the company reported that Phase 3 study met primary endpoint and six secondary endpoints across multiple disease-related abnormalities. Citigroup initiated coverage on Synageva BioPharma with a Neutral rating.
Top Low Price Stocks To Buy Right Now: Endeavour Silver Corporation(EXK)
Endeavour Silver Corp., a mid-cap silver mining company, focuses on the growth of its silver production, reserves, and resources in Mexico and Chile. It principally holds interests in two producing silver mines in Mexico, including the Guanacevi mine, located in Durango State; and the Guanajuato mine located in Guanajuato State. Endeavour Silver Corp. was formerly known as Endeavour Gold Corp. and changed its name on September 14, 2004. The company was founded in 1981 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Rich Duprey]
Yet silver miners are producing record amounts of the metal. Coeur Mining (NYSE: CDE ) said that silver production jumped 21% in the second quarter�to 4.6 million ounces, with full-year production still anticipated to hit 18 million-19.5 million ounces, while Endeavor Silver (NYSE: EXK ) hit new records as production surged 48% to 1.5 million ounces.
- [By Dan Caplinger]
Next Monday, Endeavour Silver (NYSE: EXK ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Wednesday, basic materials shares were relative leaders, up on the day by about 0.27 percent. Meanwhile, top gainers in energy sector included Endeavour Silver (NYSE: EXK), with shares up 4.3 percent, and McEwen Mining (NYSE: MUX), with shares up 4.4 percent.
Top Low Price Stocks To Buy Right Now: Plug Power Inc.(PLUG)
Plug Power Inc., an alternative energy technology provider, involves in the design, development, commercialization, and manufacture of fuel cell systems for the industrial off-road markets and stationary power markets worldwide. It develops and sells a range of fuel cell systems comprising hydrogen-fueled Proton Exchange Membrane (PEM) systems. The company?s product line includes PEM GenDrive power unit for sale on commercial terms for industrial off-road consisting of forklift or material handling applications, with a focus on multi-shift high volume manufacturing and high throughput distribution sites. It sells its products to business, industrial, and government customers through direct product sales force, original equipment manufacturers, and their dealer networks. The company was founded in 1997 and is headquartered in Latham, New York.
Advisors' Opinion:- [By Paul Ausick]
The most heavily traded Nasdaq stock today is Plug Power Inc. (NASDAQ: PLUG), as it was last Friday. The fuel cell maker to attract investors following its deal with Wal-Mart Stores Inc. (NYSE: WMT). Peer companies FuelCell Energy Inc. (NASDAQ: FCEL) and Ballard Power Systems Inc. (NASDAQ: BLDP) are also booming again today. Shares of Plug Power are set to close up 23.1% at $10.15 in a 52-week range of $0.15 to $11.41 (a new 52-week high today). Share volume was more than 7-times the daily average of around 28 million shares traded.
- [By Ben Levisohn]
Other fuel-cell companies are also feeling the pain today. Ballard Power Systems (BLDP) has dropped 1.5% to $3.86, while Plug Power (PLUG) has declined 0.9% to $5.80. Toyota Motor’s ADRs (TM) have fallen 1.2% to $115.61.
Top Low Price Stocks To Buy Right Now: Ishares Trust S & P Global * (IXJ)
iShares S&P Global Healthcare Sector Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Standard & Poor�� Global Healthcare Sector Index (the Index). The Index is a subset of the Standard & Poor�� Global 1200 Index, and measures the performance of companies that Standard & Poor�� deems to be a part of the healthcare sector. Component companies include healthcare providers, biotechnology companies, and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By MONEYMORNING.COM]
Consider the iShares S&P Global Healthcare Sect. (ETF) (NYSE: IXJ). While not a pure European play, it has one of the highest non-U.S. exposures in healthcare, most of which is European, and trades at a more reasonable P/E of 19. The fund is up 8.44% year to date and recently set a new all-time high, so it's definitely got momentum on its side.
Top Low Price Stocks To Buy Right Now: CACI International Inc. (CACI)
CACI International Inc, through its subsidiaries, provides information solutions and services to the U.S. federal government and commercial markets in North America and internationally. The company offers enterprise information technology (IT) solutions and services for the design, development, integration, deployment, operations and management, sustainment, and security of clients� infrastructure; information solutions and services that automate the knowledge management lifecycle; and enterprise-level system solutions in the domain of procurement, financial, human capital, logistics, and supply chain management. It also offers intelligence, surveillance, and reconnaissance solutions; command and control solutions to support military, homeland security, law enforcement, border security, emergency response, and disaster relief missions; and develops and manages logistics information systems, and simulation and modeling toolsets, as well as provides logistics engineering se rvices. In addition, the company offers cyber security services that support preparing for, protecting against, detecting, reacting, and responding to the cyber threats; integrated security solutions and services for mitigating and countering the effects of natural, technological, and man-made hazards; geospatial solutions relating to defense, intelligence, homeland security, and commercial applications; and government investigation and litigation support solutions. Further, it provides healthcare IT solutions; identity management solutions; program management, and system engineering and technical assistance services to government program offices; mobility solutions and services; and planning, design, implementation, and management solutions that resolve technical or business needs for commercial and government clients in the telecommunications, education, financial services, healthcare services, and transportation sectors. The company was founded in 1962 and is headquartere d in Arlington, Virginia.
Advisors' Opinion:- [By Rich Smith]
The biggest of these contracts, a sizable $179.9 million, one-year award with the potential to swell to $899.5 million if the four "option-year" extensions are exercised, is to be split among 13 separate firms:
Booz Allen Hamilton (NYSE: BAH ) CACI (NYSE: CACI ) Technologies Computer Sciences Corp (NYSE: CSC ) General Dynamics (NYSE: GD ) One Source Honeywell (NYSE: HON ) Technology Solutions Engility Corp. Lockheed Martin Science Applications International Corp. URS Federal Services and four privately held firms.Under the awarded indefinite-delivery/indefinite-quantity (IDIQ), cost-plus-fixed-fee, performance-based umbrella contract, all 13 firms will be able to compete to perform task orders for the U.S. Navy, providing "integrated cyber operations services" to Space and Naval Warfare Systems Center Atlantic.
- [By Rich Smith]
Starting the week off slow, the U.S. Department of Defense announced only a half-dozen new contracts Monday, worth a bit over $345 million in aggregate value. Raytheon scored the big win of the day -- a monster $279 million deal to develop a new electronic warfare product for the Navy. But it wasn't the day's only winner:
- [By CRWE]
CACI International Inc (NYSE:CACI) reported that it has been awarded a $45 million prime contract to provide operations and maintenance support services for the National Institutes of Health�� (NIH) Oracle e-Business suite applications.
No comments:
Post a Comment